Abstract: Disclosed herein are a novel strain of Streptomyces and a method for the production of aclacinomycins A, B, Y and aglycone thereof by cultivating the same. Streptomyces lavendofoliae DKRS(KCTC 0092BP) of the present invention is capable of producing aclacinomycins A, B, Y and aglycone with higher yield. Further, it is possible to selectively produce aclacinomycin A or Y by adjusting pH of the cultured broth of Streptomyces lavendofoliae DKRS to 4.4 or 4.6 with acetate buffer or hydrochloric acid, respectively.
Type:
Grant
Filed:
January 6, 1995
Date of Patent:
January 16, 1996
Assignees:
Dongkook Pharmaceutical Co. Ltd., Ki Beom Kwon
Inventors:
Won T. Cho, Wan S. Kim, Myung K. Kim, Jin K. Park, Hak R. Kim, Sang K. Rhee, A. G. Domracheva, T. B. Panichkina, L. A. Saburoba, L. M. Nobikoba, Y. E. Bartochevichi
Abstract: Disclosed herein are a novel strain of Streptomyces and a method for the production of aclacinomycins A, B, Y and aglycone thereof by cultivating the same. Streptomyces lavendofoliae DKRS (KCTC 0092BP) of the present invention is capable of producing aclacinomycins A, B, Y and aglycone with higher yield. Further, it is possible to selectively produce aclacinomycin A or Y by adjusting pH of the cultured broth of Streptomyces lavendofoliae DKRS to 4.4 or 4.6 with acetate buffer or hydrochloric acid, respectively.
Type:
Grant
Filed:
February 4, 1994
Date of Patent:
November 21, 1995
Assignees:
Dongkook Pharmaceutical Co., Ltd., Ki Beom Kwon
Inventors:
Won T. Cho, Wan S. Kim, Myung K. Kim, Jin K. Park, Hak R. Kim, Sang K. Rhee, A. G. Domracheva, T. B. Panichkina, L. A. Saburoba, L. M. Nobikoba, Y. E. Bartochevichi
Abstract: The present invention relates to new 1-.beta.-methyl-2-thiolic carbapenem derivatives represented by the following general formula (I) and producing method thereof. ##STR1## The above-mentioned compound is very stable against DHP-1 enzyme due to effective shielding of carbapenem ring structually and is highly effective in both gram-positive and gram-negative microorganism, especially has a remarkable effect on the Pseudomonas aeruginosa known as a disease germ having strong resistance.
Abstract: This invention relates to the process for producing ortho-isopropylated phenol derivatives having following general formula (VIII). ##STR1## (in the above formula, R.sub.1 is a hydrogen or a low alkyl group of C.sub.1 -C.sub.4)A process for producing ortho-isopropylated phenol derivatives (VIII) of the present invention is characterized by obtaining position isomer desired by means of Claisen rearrangement of phenyl allyl ether without catalyst in atmosphere, and then obtaining only one isomer by oxidation and reduction of the above-obtained position isomer. According to the present invention, ortho-alkylated phenol derivatives (VIII) having high purity at low temperature and low pressure can be prepared without producing a by-product and requirement of the complicated separation procedure.